Diversity and recognition efficiency of T cell responses to cancer.
Melanoma patients vaccinated with tumor-associated antigens frequently develop measurable peptide-specific CD8+ T cell responses; however, such responses often do not confer clinical benefit. Understanding why vaccine-elicited responses are beneficial in some patients but not in others will be impor...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2004-11-01
|
| Series: | PLoS Medicine |
| Online Access: | http://europepmc.org/articles/PMC529423?pdf=render |